Genetic Technologies, Orchid Cellmark Settle Patent Dispute | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic Technologies and Orchid Cellmark have settled a lawsuit filed by Genetic Technologies alleging patent infringement, according to a document filed last week in the US District Court for the Western District of Wisconsin.

Separately, Genetic Technologies said today that it has granted a non-exclusive license to Orchid Cellmark for a number of patents covering non-coding analysis, gene mapping, and internal standards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.